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Background
Vertically HIV-1-infected infants are at high risk of severe
manifestations of the disease in the first year of life [1]. For
this reason, we have elected, since 1996, to treat all infants
born to HIV-1-infected mothers with a combination of 3
reverse transcriptase inhibitors as soon as the diagnosis of
vertical transmission is established.
Material and methods
This is a cohort study of the effectiveness and tolerance of
therapy in the 17 HIV-1-infected infants followed from
birth in 3 belgian paediatric reference centres since 1996.
All of them had been treated according to these guide-
lines.
Results
Treatment was initiated in all patients before 66 days of
life. All but one were asymptomatic at initiation of ther-
apy. Median follow-up was 56 months (range: 26-103).
Twelve out of the 17 patients (70.6%), including 11/13
(85%) infants treated with the combination of zidovu-
dine, lamivudine and nevirapine, experienced a complete
viral suppression (<50 copies/mL) with their first drug
regimen. Lack of compliance was acknowledged by the
parents of 3 of the 5 infants whose initial regimen failed.
At last follow-up, 12 patients were asymptomatic, two
were CDC stage A and three were stage B; 15 had HIV-1
RNA levels of < 50 copies/mL and 14 had ≥25% CD4 lym-
phocytes. Among them 11 were still treated with their first
line regimen (Figure 1). One child experienced a transient
severe side effect, another child had clinical lipodystrophy
and 4 developed hypercholesterolemia.
Conclusions
Early initiation of treatment with 3 reverse transcriptase
inhibitors appeared to be highly effective in this cohort of
vertically HIV-1 infected infants. Parental adherence is
crucial to the effectiveness of therapy.
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